Cargando…
Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies
[Image: see text] The most common female endocrinopathy, polycystic ovarian syndrome (PCOS), generally affects women of childbearing age. Hippophae rhamnoides L. has been traditionally used to improve menstrual cyclicity. Gas chromatography by flame ionization detection analysis showed that it conta...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500670/ https://www.ncbi.nlm.nih.gov/pubmed/37720770 http://dx.doi.org/10.1021/acsomega.3c04720 |
_version_ | 1785105958040502272 |
---|---|
author | Hussain, Liaqat Rana, Saba Abbas, Ghulam Alshammari, Abdulrahman Alasmari, Abdullah F. Alharbi, Metab Zahid, Muhammad Toseef Irfan, Muhammad |
author_facet | Hussain, Liaqat Rana, Saba Abbas, Ghulam Alshammari, Abdulrahman Alasmari, Abdullah F. Alharbi, Metab Zahid, Muhammad Toseef Irfan, Muhammad |
author_sort | Hussain, Liaqat |
collection | PubMed |
description | [Image: see text] The most common female endocrinopathy, polycystic ovarian syndrome (PCOS), generally affects women of childbearing age. Hippophae rhamnoides L. has been traditionally used to improve menstrual cyclicity. Gas chromatography by flame ionization detection analysis showed that it contained various phytoconstituents such as omega-3 fatty acid, phytosterols, palmitic acid, oleic acid, and linoleic acid. H. rhamnoides L. (HR) nano-emulsion was also formulated. HR and its encapsulated nano-emulsion (HRNE) were evaluated for the treatment of PCOS. Thirty-five healthy female adult albino rats were acquired and divided into seven groups (n = 5). Letrozole (1 mg/kg) was used for 5 weeks to induce the disease. To confirm disease (PCOS) induction, the animals were weighed weekly and their vaginal smears were analyzed daily under a microscope. After PCOS induction, animals were treated with metformin, HR, and HRNE with two different doses (0.5/kg and 1 g/kg, p.o.) for 5 weeks. At the end of the treatment, animals were euthanized, and blood was collected for hormonal assessment, lipid profiling, and liver functioning test assessment. Both the ovaries were preserved for histopathology and liver for the purpose of assessment of antioxidant potential. The results revealed that HR and HRNE at both doses improved the hormonal imbalance; follicle-stimulating hormone, estrogen, and progesterone levels are increased, while luteinizing hormone surge and testosterone level are controlled. Insulin sensitivity is improved. Ovarian histopathology showed that normal ovarian echotexture is restored with corpus luteum and mature and developing follicles. HR and HRNE also improved the lipid profile and decreased lipid peroxidation (MDA) with improved antioxidant markers (SOD, CAT, and GSH). Results were statistically analyzed by one-way analysis of variance and were considered significant only if p < 0.05. In conclusion, it can be postulated that H. rhamnoides L. proved effective in the management of PCOS and its nano-emulsion effects were statistically more significant, which might be due to better bioavailability. |
format | Online Article Text |
id | pubmed-10500670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-105006702023-09-15 Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies Hussain, Liaqat Rana, Saba Abbas, Ghulam Alshammari, Abdulrahman Alasmari, Abdullah F. Alharbi, Metab Zahid, Muhammad Toseef Irfan, Muhammad ACS Omega [Image: see text] The most common female endocrinopathy, polycystic ovarian syndrome (PCOS), generally affects women of childbearing age. Hippophae rhamnoides L. has been traditionally used to improve menstrual cyclicity. Gas chromatography by flame ionization detection analysis showed that it contained various phytoconstituents such as omega-3 fatty acid, phytosterols, palmitic acid, oleic acid, and linoleic acid. H. rhamnoides L. (HR) nano-emulsion was also formulated. HR and its encapsulated nano-emulsion (HRNE) were evaluated for the treatment of PCOS. Thirty-five healthy female adult albino rats were acquired and divided into seven groups (n = 5). Letrozole (1 mg/kg) was used for 5 weeks to induce the disease. To confirm disease (PCOS) induction, the animals were weighed weekly and their vaginal smears were analyzed daily under a microscope. After PCOS induction, animals were treated with metformin, HR, and HRNE with two different doses (0.5/kg and 1 g/kg, p.o.) for 5 weeks. At the end of the treatment, animals were euthanized, and blood was collected for hormonal assessment, lipid profiling, and liver functioning test assessment. Both the ovaries were preserved for histopathology and liver for the purpose of assessment of antioxidant potential. The results revealed that HR and HRNE at both doses improved the hormonal imbalance; follicle-stimulating hormone, estrogen, and progesterone levels are increased, while luteinizing hormone surge and testosterone level are controlled. Insulin sensitivity is improved. Ovarian histopathology showed that normal ovarian echotexture is restored with corpus luteum and mature and developing follicles. HR and HRNE also improved the lipid profile and decreased lipid peroxidation (MDA) with improved antioxidant markers (SOD, CAT, and GSH). Results were statistically analyzed by one-way analysis of variance and were considered significant only if p < 0.05. In conclusion, it can be postulated that H. rhamnoides L. proved effective in the management of PCOS and its nano-emulsion effects were statistically more significant, which might be due to better bioavailability. American Chemical Society 2023-08-28 /pmc/articles/PMC10500670/ /pubmed/37720770 http://dx.doi.org/10.1021/acsomega.3c04720 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Hussain, Liaqat Rana, Saba Abbas, Ghulam Alshammari, Abdulrahman Alasmari, Abdullah F. Alharbi, Metab Zahid, Muhammad Toseef Irfan, Muhammad Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies |
title | Pharmacological
Potential of Hippophae
rhamnoides L. Nano-Emulsion for Management of Polycystic
Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies |
title_full | Pharmacological
Potential of Hippophae
rhamnoides L. Nano-Emulsion for Management of Polycystic
Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies |
title_fullStr | Pharmacological
Potential of Hippophae
rhamnoides L. Nano-Emulsion for Management of Polycystic
Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies |
title_full_unstemmed | Pharmacological
Potential of Hippophae
rhamnoides L. Nano-Emulsion for Management of Polycystic
Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies |
title_short | Pharmacological
Potential of Hippophae
rhamnoides L. Nano-Emulsion for Management of Polycystic
Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies |
title_sort | pharmacological
potential of hippophae
rhamnoides l. nano-emulsion for management of polycystic
ovarian syndrome in animals’ model: in vitro and in vivo studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500670/ https://www.ncbi.nlm.nih.gov/pubmed/37720770 http://dx.doi.org/10.1021/acsomega.3c04720 |
work_keys_str_mv | AT hussainliaqat pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT ranasaba pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT abbasghulam pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT alshammariabdulrahman pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT alasmariabdullahf pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT alharbimetab pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT zahidmuhammadtoseef pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies AT irfanmuhammad pharmacologicalpotentialofhippophaerhamnoideslnanoemulsionformanagementofpolycysticovariansyndromeinanimalsmodelinvitroandinvivostudies |